{"event":"flu-season-2026-27-tracker","title":"Flu season 2026-27 tracker: vaccine strains, subclade K, surveillance","state":"developing","updated":"2026-11-14T00:00:00.000Z","entries":[{"id":"1a99bde","at":"2026-11-07T00:00:00.000Z","title":"US activity keeps rising; CDC estimates 2.6 million illnesses so far","status":"confirmed","body":"Week 44 FluView, published 13 November. Severity was still rated low across all ages.","cites":[{"id":"upk-hlt-flu-w44-rising","n":3,"url":"https://www.cdc.gov/fluview/surveillance/2026-week-44.html","publisher":"US Centers for Disease Control and Prevention","short":"US Centers for Disease…"},{"id":"upk-hlt-flu-w44-burden","n":27,"url":"https://www.cdc.gov/fluview/surveillance/2026-week-44.html","publisher":"US Centers for Disease Control and Prevention","short":"US Centers for Disease…"},{"id":"upk-hlt-flu-w44-pediatric","n":28,"url":"https://www.cdc.gov/fluview/surveillance/2026-week-44.html","publisher":"US Centers for Disease Control and Prevention","short":"US Centers for Disease…"}]},{"id":"1u03eqr","at":"2026-11-06T00:00:00.000Z","title":"ECDC reports low but increasing influenza in the EU/EEA","status":"confirmed","cites":[{"id":"flu-ecdc-w44","n":5,"url":"https://www.ecdc.europa.eu/en/publications-data/weekly-respiratory-virus-update-week-44-october-2026","publisher":"European Centre for Disease Prevention and Control","short":"European Centre…"}]},{"id":"jjckt3","at":"2026-10-31T00:00:00.000Z","title":"US flu activity rising earlier than usual, mostly H1N1","status":"confirmed","cites":[{"id":"flu-fluview-w43-rising","n":33,"url":"https://www.cdc.gov/fluview/surveillance/2026-week-43.html","publisher":"US Centers for Disease Control and Prevention","short":"US Centers for Disease…"},{"id":"flu-fluview-w43-subtypes","n":34,"url":"https://www.cdc.gov/fluview/surveillance/2026-week-43.html","publisher":"US Centers for Disease Control and Prevention","short":"US Centers for Disease…"},{"id":"flu-fluview-w43-burden","n":35,"url":"https://www.cdc.gov/fluview/surveillance/2026-week-43.html","publisher":"US Centers for Disease Control and Prevention","short":"US Centers for Disease…"}]},{"id":"plprqp","at":"2026-10-01T00:00:00.000Z","title":"VRBPAC meets on 2027 southern hemisphere strains","status":"confirmed","cites":[{"id":"flu-vrbpac-oct-2026","n":31,"url":"https://www.fda.gov/media/195133/download","publisher":"US Food and Drug Administration","short":"US Food and Drug…"}]},{"id":"gfvkij","at":"2026-09-25T00:00:00.000Z","title":"WHO keeps the same strains for the 2027 southern hemisphere","status":"confirmed","cites":[{"id":"flu-who-sh-2027","n":14,"url":"https://www.who.int/news/item/25-09-2026-recommendations-announced-for-influenza-vaccine-composition-for-the-2027-southern-hemisphere-influenza-season","publisher":"World Health Organization","short":"World Health Organization"},{"id":"flu-who-feb-aug-2026","n":30,"url":"https://www.who.int/news/item/25-09-2026-recommendations-announced-for-influenza-vaccine-composition-for-the-2027-southern-hemisphere-influenza-season","publisher":"World Health Organization","short":"World Health Organization"}]},{"id":"1hkk8gi","at":"2026-05-26T00:00:00.000Z","title":"EMA completes amendments with the cell-based H3N2 strain","status":"confirmed","cites":[{"id":"flu-ema-amendments","n":10,"url":"https://www.ema.europa.eu/en/news/eu-recommendations-2026-2027-seasonal-flu-vaccine-composition","publisher":"European Medicines Agency","short":"European Medicines Agency"},{"id":"flu-ema-2026-27-composition","n":11,"url":"https://www.ema.europa.eu/en/news/eu-recommendations-2026-2027-seasonal-flu-vaccine-composition","publisher":"European Medicines Agency","short":"European Medicines Agency"}]},{"id":"11uml7i","at":"2026-03-30T00:00:00.000Z","title":"EMA publishes EU 2026/27 recommendation","status":"confirmed","cites":[{"id":"flu-ema-amendments","n":10,"url":"https://www.ema.europa.eu/en/news/eu-recommendations-2026-2027-seasonal-flu-vaccine-composition","publisher":"European Medicines Agency","short":"European Medicines Agency"},{"id":"flu-ema-role","n":32,"url":"https://www.ema.europa.eu/en/news/eu-recommendations-2026-2027-seasonal-flu-vaccine-composition","publisher":"European Medicines Agency","short":"European Medicines Agency"},{"id":"flu-ema-no-yamagata","n":12,"url":"https://www.ema.europa.eu/en/news/eu-recommendations-2026-2027-seasonal-flu-vaccine-composition","publisher":"European Medicines Agency","short":"European Medicines Agency"}]},{"id":"76a34f","at":"2026-03-13T00:00:00.000Z","title":"FDA issues 2026-27 US composition","status":"confirmed","cites":[{"id":"flu-fda-final-us","n":8,"url":"https://www.cdc.gov/flu/season/2026-2027.html","publisher":"US Centers for Disease Control and Prevention","short":"US Centers for Disease…"}]},{"id":"mfqv7z","at":"2026-03-12T00:00:00.000Z","title":"FDA advisers back the WHO strains 7-0","status":"confirmed","cites":[{"id":"flu-vrbpac-vote","n":7,"url":"https://www.fda.gov/media/192383/download","publisher":"US Food and Drug Administration","short":"US Food and Drug…"},{"id":"flu-vrbpac-change-all","n":20,"url":"https://www.fda.gov/media/192383/download","publisher":"US Food and Drug Administration","short":"US Food and Drug…"}]},{"id":"8i40ym","at":"2026-03-12T00:00:00.000Z","title":"CDC interim estimates show reduced 2025-26 protection","status":"confirmed","body":"Effectiveness against hospitalisation was 41% in children and 30% in adults, with subclade K making up 93% of characterised H3N2 samples.","cites":[{"id":"flu-ve-2025-26-interim","n":18,"url":"https://www.cdc.gov/mmwr/volumes/75/wr/mm7509a2.htm","publisher":"US Centers for Disease Control and Prevention (MMWR)","short":"US Centers for Disease…"},{"id":"flu-mmwr-k-drifted","n":19,"url":"https://www.cdc.gov/mmwr/volumes/75/wr/mm7509a2.htm","publisher":"US Centers for Disease Control and Prevention (MMWR)","short":"US Centers for Disease…"}]},{"id":"19ctk4l","at":"2026-02-27T00:00:00.000Z","title":"WHO recommends 2026-27 northern hemisphere strains, changing all three","status":"confirmed","body":"The H3N2 component moves to subclade K viruses (A/Darwin/1454/2025 for egg-based, A/Darwin/1415/2025 for cell-based vaccines).","cites":[{"id":"flu-who-nh-2026-27-composition","n":6,"url":"https://www.who.int/publications/m/item/recommended-composition-of-influenza-virus-vaccines-for-use-in-the-2026-2027-northern-hemisphere-influenza-season","publisher":"World Health Organization","short":"World Health Organization"},{"id":"flu-who-all-three-changed","n":1,"url":"https://cdn.who.int/media/docs/default-source/vcm-northern-hemisphere-recommendation-2026-2027/b.-27-feb-2026-frequently-asked-questions.pdf?sfvrsn=66208818_7","publisher":"World Health Organization","short":"World Health Organization"}]}]}